Hydrogel enhanced PET surface for β-isotope brachytherapy during balloon angioplasty and stent implantation
- Summary
- Judah Weinberger M.D., Ph.D.
- Technology Benefits
- Provides targeted drug delivery during arterial interventionsReduces drug toxicity Reduces radiation exposureReduces restenosis Patent information:Patent Issued (US 5,503,613)Tech Ventures Reference: IR 1059
- Technology Application
- Brachytherapy to reduce restenosis after arterial interventions such as angioplasty and stent implantations
- Detailed Technology Description
- Judah Weinberger M.D., Ph.D.
- *Abstract
-
None
- *Inquiry
- Jerry KokoshkaColumbia Technology VenturesTel: (212) 854-8444Email: TechTransfer@columbia.edu
- *IR
- 1059
- *Principal Investigator
-
- *Publications
- US 7,192,395
- Country/Region
- USA
For more information, please click Here

